| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |